JMP Securities Reiterates Outperform Rating for Vertex Pharmaceuticals Incorporated

JMP Securities Reiterates Outperform Rating for Vertex Pharmaceuticals Incorporated


's stock had its "outperform" rating restated by research analysts at JMP Securities in a research note issued to investors on Wednesday, The Fly reports. A number of other equities analysts have also issued reports on the company.



from Biotech News